In animal models of MS, Alzheimer's disease, and Parkinson's disease, KIF5 levels are significantly downregulated and are associated with NF, APP, and α-synuclein aggregations (Stokin et al., 2005; Chu et al., 2012; Kreutzer et al., 2012). Here, APP is linked to early-onset autosomal dominant Alzheimer disease.